⚲
|
Repligen Corp | |
---|---|
Ticker | RGEN |
CIK # | 0000730272 |
CUSIP | 759916109 |
Sector | Life Sciences |
Industry | Biological Products, (No Disgnostic Substances) |
Phone | 7814499560 |
Address | 41 Seyon Street Building 1, Suite 100 Waltham, MA 02453 |
Source | [EDGAR] |
Market Cap, 13F ($) |
---|
Business |
---|
to "Repligen Corporation", "Repligen", "we", "us", "our", or the "Company" refer to Repligen Corporation and its subsidiaries, taken as a whole, unless the context otherwise indicates. Repligen Corporation is a global life sciences company that develops and commercializes highly innovative bioprocessing technologies and systems that increase efficiencies and flexibility in the process of manufacturing biological drugs. As the overall market for biologics continues to grow and expand, our customers - primarily large biopharmaceutical companies and contract development and manufacturing organizations - face critical production cost, capacity, quality and time pressures. Built to address these concerns, our products are helping to set new standards for the way biologics are manufactured. We are committed to inspiring advances in bioprocessing as a trusted partner in the production of critical biologic drugs - including monoclonal antibodies ("mAb"), recombinant proteins, vaccines and gene therapies - that are improving human health worldwide. |
CIK | Filing | 2011 - 2023 |
---|---|---|
[0000730272] | 10-K | |
[0000730272] | 10-Q | |
[0000730272] | 3 | |
[0000730272] | 4 | |
[0000730272] | 5 | |
[0000730272] | 8-K | |
[0000730272] | D | |
[0000730272] | SC 13G |
Form 13D/13G Filer | Form 13D/13G Subject | Filed | % Owned |
---|---|---|---|
BlackRock Inc | Repligen Corp | [2022-09-08] | 10.2 |
Price T Rowe Associates Inc /MD/ | Repligen Corp | [2022-02-14] | 5.5 |
TimesSquare Capital Management LLC | Repligen Corp | [2018-02-14] | 5.8 |
Vanguard Group Inc | Repligen Corp | [2018-02-09] | 6.48 |
Eddleman Roy T | Repligen Corp | [2017-08-21] | 11.0 |
OppenheimerFunds Inc | Repligen Corp | [2016-02-04] | 5.67 |
FMR LLC | Repligen Corp | [2015-02-13] | 0.0 |
Invesco Ltd | Repligen Corp | [2015-02-11] | 5.3 |
Northpointe Capital LLC | Repligen Corp | [2013-02-11] | 7.4 |
BlackRock Inc | Repligen Corp | [2013-01-30] | 5.93 |